Clinical trial
Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism
NCT00273650 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00273650 |
|---|---|
| Title | Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism |
| Official title | Double-Blind Placebo Controlled, Cross-over Trial of Subcutaneous B12 on Behavioral and Metabolic Measures in Children With Autism. |
| Lead sponsor | University of California, San Francisco, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Autistic Disorder |
| Intervention type | Drug, Other |
| Interventions | methylcobalamin, saline placebo |
| Enrollment | 30 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jan 9, 2006 |
| Last update posted | Oct 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: